“I am concerned by the FDA’s slow action, over multiple administrations, to protect patients from this product despite early warning signs,” one U.S. representative said in an open letter. 

The new analysis, published in the Journal of the American Heart Association, included patient data from the last three decades. 

The advanced AI model outperformed a team of cardiologists, delivering a better AUC and overall accuracy. 

Diabetes appears to be yet another potential outcome associated with long COVID-19. 

Some of the study's findings even raised concerns that losartan could be harming these patients. 

Researchers examined data from more than 208,000 patients, sharing their findings in JACC: CardioOncology. 

It is unclear if imaging abnormalities represent persistent scarring, and whether they may regress over time or lead to pulmonary fibrosis, experts wrote in Radiology.